Spinal Bone Growth Stimulators Market by Type of Stimulators (Implantable Bone Growth Stimulators, External Bone Growth Stimulators), by Application (Degenerative Disc Disease, Spinal Fusion, Facture Healing), by End Users (Hospitals, Ambulatory surgical centres (ASCs) , Home Care, Orthopaedic Centre), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa): Global Opportunity Analysis and Industry Forecast, 2023-2031

The Global Spinal Bone Growth Stimulators Market was valued at $XX million in 2022. It is projected to grow at a CAGR of XX% from 2023 to 2031 and reach more than $XX million by the end of 2031. 

Spinal Bone Growth Stimulators Market Analysis:

Bone growth and fusion in a surgically treated spinal segment can be stimulated by specialized medical devices called bone stimulators, which emit low-voltage electric currents. The newly formed bone grows in the interbody space and fuses the treated spinal segments. Bone stimulators can either be implanted (internal) or worn outside the body (external). There are 3 different types of electrical stimulation: Direct current stimulation, Pulsed electromagnetic field stimulation, Capacitive coupled electrical stimulation. Due to high costs and inconsistent results, only 32% of spine surgeons use bone stimulators to enhance spinal fusion in their patients.

The impact of COVID-19 on the studied market is expected to be significant. On one hand, due to the lockdown and travel restriction imposed to combat the transmission of the COVID-19 virus, incidences of road accidents and consequent fractures and injuries have reduced, which has highly impacted the studied market. On the other hand, as per a research article published in the Journal of Clinical Pharmacy and Therapeutics, 2020, the elderly population became more prone to bone fractures during the pandemic due to lack of out-of-home activities, sedentary lifestyle, and decreased exposure to sunlight and consequent Vitamin D deficiency. Additionally, as per a research study published in Bone and Joint Open, 2020, there was a significant increase in hip fractures, especially among the elderly population in the United Kingdom, during the pandemic, which was majorly attributed to the lack of caretakers and relatives to take care of the aged people. Thus, the increasing incidence of fractures and trauma cases among the elderly population during the pandemic turns the spotlight on the bone growth stimulators, in turn driving the growth of the studied market.. The bone growth stimulator market is majorly driven by factors such as the rising incidence of bone and joint disorders, growing demand for non-invasive and minimally invasive surgeries across the world, and the growing geriatrics population.

An increasing incidence of trauma and accident cases worldwide is considered as one of the major factors likely to boost the demand for the studied market. According to the National Safety Council, in 2018, around 4.5 million people were severely injured due to accidents. Thus, given the aforementioned factors, the bone growth stimulator market is expected to witness significant growth over the forecast period globally. The rising incidence of age-related disorders (such as rheumatoid arthritis, osteoarthritis, osteoporosis, and fractures) and sports injuries drives the demand for non-invasive and minimally invasive surgical treatments worldwide.

Minimally invasive therapeutic procedures are increasingly being preferred owing to their benefits, such as painless treatment, reduced postoperative hospital stay, reduced surgical trauma, limited tissue scarring, reduced surgical risks, improved patient care, shorter postoperative recovery periods, and greater affordability. These procedures are used for a broad range of spinal disorders, such as spondylosis/spondylolisthesis, stenosis, pseudarthrosis, fractures, trauma, and bone healing.

In February 2020, Orthofix Medical Inc. received US FDA approval for its STIM on Track, mobile app version 2.1 to advance the treatment with its bone growth stimulators such as CervicalStim, SpinalStim, and PhysioStim.

In January 2020, Medtronic acquired Stimgenics to expand its portfolio in the Differential Target Multiplexed Spinal Cord Stimulation Therapy.

Spinal Bone Growth Stimulators Market Trends:

The spinal bone growth stimulators market is subject to several notable trends that are shaping the industry and influencing the development and adoption of these devices. The field of bone growth stimulation is constantly evolving, with ongoing technological advancements leading to the development of more sophisticated and effective devices. This includes the integration of advanced materials, sensors, and patient monitoring technologies. There is a growing trend toward minimally invasive spinal surgeries, and this trend is driving the use of bone growth stimulators that can be used in conjunction with less invasive procedures. These devices are designed to minimize tissue disruption and speed up the recovery process.

Device manufacturers are increasingly focusing on patient-centric design, making bone growth stimulators more user-friendly and convenient for patients. This includes devices that are wearable, portable, and comfortable for extended use. External bone growth stimulators designed for home use are becoming more prevalent. These devices allow patients to continue treatment outside of clinical settings, improving compliance and patient outcomes. Physicians are exploring the use of bone growth stimulators in combination with other treatment modalities, such as regenerative medicine and pharmaceuticals, to enhance healing and fusion outcomes. Tailoring treatment to the individual patient is becoming more common. Personalized treatment plans, including the use of bone growth stimulators, may improve the overall success of spinal fusion and fracture healing. The use of remote monitoring and telehealth technologies has become increasingly important, allowing healthcare providers to track patient progress and ensure compliance with treatment regimens.

The external bone growth stimulators are expected to witness a significant market share over the forecast period. The advanced features of external bone growth stimulators, namely their light weight, ease of handling, and portability, act as a major driver for the growth of the current segment.

According to the research study published in Bone and Joint Open, 2020, in 2020, there was an increase in fractures and minor injuries requiring surgery among elderly patients during the COVID-19 lockdown in the United Kingdom, as compared to 2019. Though there was an increase in minor injuries requiring minor surgeries, the numbers of polytrauma and open fractures were reduced during the COVID-19 era due to a reduction in road traffic and in participation in outdoor sports activities. Thus, COVID-19 is expected to impact the studied market significantly during the pandemic era.

The demand for these products is increasing due to the rising number of bone fracture cases and the effectiveness of the external bone growth stimulators in healing fractures. According to a research article published in the Archives of Osteoporosis, 2020, fragility fractures in the largest five countries of the European Union plus Sweden (EU6) accounted for 2.7 million in 2017, and is expected to reach 3.3 million in 2030, which is a 23% increase from 2017. Additionally, as per the research study published in the Orthopedic Trauma Association International, 2020,14% of the Australian population have osteoporosis and 60,000 hip fractures have been estimated to occur by 2050 in Australia. This indicates the rising burden of fracture across the world. Therefore, there is a growing demand for external bone growth stimulators, which will contribute to the growth of the market for the same over the forecast period.

Spinal Bone Growth Stimulators By Type of Stimulators Segmentation:

Based on the Type of Stimulators the market is Implantable Bone Growth Stimulators, External Bone Growth Stimulators. Implantable Bone Growth Stimulators: These are surgically implanted devices that provide a constant electrical or electromagnetic stimulus directly to the affected area of the spine. External Bone Growth Stimulators: These are non-invasive devices worn outside the body that emit electrical or electromagnetic signals to stimulate bone growth. They are usually used after spinal surgery.

Spinal Bone Growth Stimulators By Application Segmentation: 

Based on Application the market is divided into Degenerative Disc Disease, Spinal Fusion, Facture Healing. Spinal Fusion: Bone growth stimulators are commonly used to promote fusion of the vertebrae in the spine. This is often necessary after spinal surgeries. Fracture Healing: Stimulators can aid in the healing of spinal fractures, whether they are due to trauma or osteoporosis. Degenerative Disc Disease: In some cases, stimulators may be used to support the healing of degenerative disc disease, especially in the cervical spine.

Spinal Bone Growth Stimulators By End User Segmentation: 

Based on end Users the market is divided into Hospitals, Ambulatory surgical centres (ASCs) , Home Care , Orthopaedic Centre. Hospitals: Hospitals are primary users of bone growth stimulators for spine-related surgeries and treatments. Orthopedic Clinics: Specialized orthopedic clinics may use these devices to treat patients with spine-related issues. Ambulatory Surgical Centers (ASCs): Outpatient surgery centers may use bone growth stimulators in minimally invasive spinal procedures. Home Care: Some external bone growth stimulators are designed for home use, allowing patients to continue treatment outside of clinical settings.

Spinal Bone Growth Stimulators Market Leaders

• Orthofix US LLC
• Stryker
• Medical Device Business Services, Inc.,
•  Bioventus, Medtronic,
• DJO, LLC,
•  Zimmer Biomet,
• Arthrex, Inc.,
• Terumo Corporation,
• Ossatec Benelux BV.

These companies contribute significantly to the growth and innovation within the Spinal Bone Growth Stimulators market, offering a wide range of solutions to meet the diverse needs of the biopharmaceutical, biotechnology, and research industries.

• In 2022, Orthofix Medical Inc. (US) received FDA premarket approval for the AccelStim Bone Growth Stimulation Device.
• In 2021, The company announced the competition of its spinoff of ZimVie. The spinoff marks a major milestone in the active portfolio management of Zimmer Biomet.